成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> Journal Der Deutschen Dermatologischen Gesellschaft >>article
Journal Der Deutschen Dermatologischen Gesellschaft

Journal Der Deutschen Dermatologischen Gesellschaft

IF: 5.5
Download PDF

Intravenous treatment of calcinosis cutis with sodium thiosulfate – A case series

Published:9 August 2024 DOI: 10.1111/ddg.15509 PMID: 39118582
Tom Bruns, Cord Sunderk?tter, Johannes Wohlrab

Abstract

Calcinosis cutis is defined as the deposition of calcium salts in the skin. The dystrophic form is the most common and usually occurs in chronic inflammatory processes associated with collagenoses. Therapeutic options include surgical excision as well as a few pharmacological treatments. Overall, the evidence for the known therapeutic interventions is very limited and there is a lack of valid recommendations. Intravenous sodium thiosulfate has been used successfully in the treatment of calciphylaxis. In our case series, five patients with dystrophic calcinosis cutis received intravenous sodium thiosulfate for at least six cycles on five consecutive days per month, with single doses of 12.5?g and 25.0?g, respectively. A reduction in the calcified lesions could not be proven with certainty, but stable disease conditions were achieved. Intravenous sodium thiosulfate may counteract the progression of calcinosis cutis. The successful use of epicutaneously applied sodium thiosulfate, as described in the literature, suggests that a higher cutaneous bioavailability can be achieved to exert a lytic effect on calcinosis cutis. This is further supported by the reported efficacy of high-dose sodium thiosulfate in the treatment of calciphylaxis.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Sodium thiosulfate 7772-98-7 Na2O3S2 830 suppliers $6.00-$1420.00

Similar articles

IF:1.4

Sodium thiosulfate: new hope for the treatment of calciphylaxis.

Seminars in Dialysis Melvin R Hayden, David J A Goldsmith,etc Published: 1 May 2010
IF:3.4

Sodium Thiosulfate: Pediatric First Approval.

Pediatric Drugs Sohita Dhillon,etc Published: 1 March 2023